Athos Capital’s Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CHEB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-37,499
Closed -$337K 47
2025
Q2
$337K Buy
+37,499
New +$2.91K 0.5% 24

Other funds holding CHEB.WS

Athos Capital's CHEB.WS Position: Q3 2025 in Review

Athos Capital sold out of Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CHEB.WS) in Q3 2025, closing a stake of 37,499 shares — an estimated $337K sold.

Athos Capital first reported a position in CHEB.WS in Q2 2025 and held it in 1 quarter. The position peaked at $337K in Q2 2025. 1 fund tracked by Wall St. Rank holds CHEB.WS as of Q3 2025.

  • Athos Capital reported no remaining Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2025 after selling out during the quarter.
  • Athos Capital sold 37,499 Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2025, an estimated $337K.
  • Athos Capital first reported a position in Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2025 and held it in 1 quarter.
  • Athos Capital's Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $337K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2025.

Based on Athos Capital's 13F filing for Q3 2025, filed 13 Nov 2025.